Malignant melanoma is one of the most aggressive human cancers. Invasion of cells is the first step in metastasis, resulting in cell migration through tissue compartments. We aimed to evaluate genomic alterations specifically associated with the invasive characteristics of melanoma cells. Matrigel invasion assays were used to determine the invasive properties of cell lines that originated from primary melanomas. Array comparative genomic hybridization analyses were carried out to define the chromosome copy number alterations (CNAs). Several recurrent CNAs were identified by array comparative genomic hybridization that affected melanoma-related genes. Invasive primary cell lines showed high frequencies of CNAs, including the loss of 7q and gain of 12q chromosomal regions targeting PTPN12, ADAM22, FZD1, TFPI2, GNG11, COL1A2, SMURF1, VGF, RELN and GLIPR1 genes. Gain of the GDNF (5p13.1), GPAA1, PLEC and SHARPIN (8q24.3) genes was significantly more frequent in invasive cell lines compared with the noninvasive ones. Importantly, copy number gains of these genes were also found in cell lines that originated from metastases, suggesting their role in melanoma metastasis formation. The present study describes genomic differences between invasive and noninvasive melanoma cell lines that may contribute toward the aggressive phenotype of human melanoma cells. Melanoma Res 26:100-107 Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Malignant melanoma is considered one of the most aggressive human cancers because of its high metastatic propensity [1] [2] [3] [4] [5] . Cutaneous melanoma develops from melanocytes, which originate from highly motile neural crest progenitors that migrate through the skin during embryonic development [6, 7] . The efficacy of current therapies is not a question of tumour stage, but is dependent on the individual genetic alterations, mutational status and rapid progression of melanoma tumours [8] .
Metastasis formation of primary tumours is a multistep process that includes tumour cell invasion, intravasation to vessels, survival in the circulatory system, extravasation and proliferation, leading to metastatic colonization [9] [10] [11] . The acquisition of invasive potential is one of the key transitions in the progression of benign tumours to life-threatening metastatic melanoma [12] . To efficiently metastasize, invasive melanoma cells alter their cytoskeletal organization and alter their contacts with the extracellular matrix and the surrounding stroma [2] . Apart from the collective invasive strategy, where cells invade as multicellular units by forming strands or sheets, individual tumour cells can also migrate through tissue compartments separated by the basement membrane [2, 10, 11] . Furthermore, the invasive strategy of melanoma cells depends on the microenvironment and the effects of therapeutic regimens [13] [14] [15] [16] .
Numerous genetic alterations (e.g. BRAF, NRAS, RAC1 mutations) and deregulated signalling pathways (e.g. altered activity of Rho GTPases, MAPK and PI3K molecules) have been shown to be associated with invasive behaviour [2, 12, [17] [18] [19] [20] . Despite these essential therapeutic targets, an effective overall therapy is still missing [21, 22] . Although our knowledge of melanoma cell motility has increased in the last decades, the complexity of the diverse invasive strategies requires further research [9, 13, 14, 23] .
In an effort to further advance the understanding of the relationship between copy number (CN) alterations and the invasiveness of melanoma, we carried out array comparative genomic hybridization (aCGH) analyses on All supplementary digital content is available directly from the corresponding author.
18 melanoma cell lines. This study has important implications for understanding the complexity of melanoma development and progression.
Methods

Cell culture
Melanoma cell lines (WM35, HT199, A2058, HT168, M24, M24 MET) were obtained from the American Type Culture Collection (Manassas, Virginia, USA) and the other cell lines (WM1789, WM793B, WM3211, WM1361, WM902B, WM39, WM278, WM983A, WM1366, WM3248, WM1617, WM983B) were from the Coriell Institute for Medical Research (Camden, New Jersey, USA). The clinicopathological characteristics of the cell lines are summarized in Table 1 . The cells were cultured in RPMI 1640 medium (Lonza Group Ltd, Basel, Switzerland) or MCDB153-L15 medium (SigmaAldrich Co. LCC, St Louis, Missouri, USA) supplemented with 5-10% foetal bovine serum (Gibco, Carlsbad, California, USA) at 37°C in an atmosphere containing 5% CO 2 . Genomic DNA was isolated using the G-spin Genomic DNA extraction kit (Intron Biotechnology Inc., Seongnam, Korea) according to the manufacturer's protocol. The concentration and quality of the DNA were determined using a NanoDrop ND-1000 UV-visible spectrophotometer. The ratio of the absorbance at 260 and 280 nm was used to determine the purity of the DNA (a ratio ≥ 1.8 was considered to indicate high quality). The integrity of the DNA was verified by standard 1.2% agarose gel electrophoresis.
aCGH and data analysis DNA samples were hybridized to Cytochip ISCA 8 × 60 arrays (BlueGnome Ltd, Cambridge, UK) with increased probe density in regions or genes associated with known constitutional disorders. Array data were analysed using BlueFuse Multi v2.2 software (BlueGnome Ltd) and Nexus Copy Number 6.1 software (BioDiscovery Inc., Hawthorne, California, USA). To adjust the sensitivity of the segmentation algorithm, we determined a significance threshold of 1.0E − 6 and specified 1000 kbp as the maximum spacing between adjacent probes. To eliminate small copy number alterations (CNAs), the minimum number of probes per segment was set at 5. To detect gains and losses, the following log2 ratio thresholds were set: 0.3 for gains and losses, 0.6 for high CN gains and − 1.0 for homozygous deletions. Significantly different CN events between invasive versus noninvasive melanoma cell lines were identified using twosided Fisher's exact test. The FDR adjustment was calculated to correct for multiple testing using the Nexus Copy Number 6.1 Comparison feature. To avoid sex bias, all probes on chromosomes X and Y were discarded.
In-vitro invasion assay
The invasive potential of the melanoma cell lines was analysed using BD Biocoat Matrigel invasion chambers (pore size: 8 μm, 24-well; BD Biosciences, Bedford, Massachusetts, USA). The upper chamber of the insert was filled with 500 µl of cell suspension in serum-free media (5 × 10 4 cells/well). Medium containing 10% FBS was applied to the lower chamber as a chemoattractant. After the cells were incubated for 24 h at 37°C, cells in the lower layer were fixed with methanol and stained 
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with haematoxylin-eosin. The invaded cells were counted using a light microscope in seven different visual fields at × 200 magnification and the data are presented as the means SD of three independent experiments.
Detection of BRAF and NRAS mutations
The BRAF and NRAS mutation status of the melanoma cell lines A2058, HT168, M24, M24 MET, HT199 and WM902B was determined. All the other cell lines were tested previously for these mutations (data provided by the ATCC or Coriell Institute). The mutations in codon 600 of BRAF and codon 61 of NRAS were analysed on a LightCycler real-time PCR System (Roche Diagnostics GmbH, Mannheim, Germany) by melting curve analysis using fluorescent probes. Primers and probes were purchased from TIB Molbiol (Berlin, Germany) and the reaction was performed as described previously [24] . The mutation status of the analysed cell lines is shown in Table 1 .
TaqMan copy number assay
The real-time quantitative PCR (qPCR) method was used on 18 melanoma cell lines to confirm the aCGH results. CNs of GLIPR1, COL1A2 and RELN genes were assessed using predesigned TaqMan copy number assays as described previously [25] . Predesigned TaqMan copy number assays were used to analyse CNs (Hs01421756_cn, Hs03071873_cn and Hs02363915_cn, respectively), and the RNase P gene was used as a reference gene (Applied Biosystems Inc., Carlsbad, California, USA). All assays were performed using the TaqMan Universal PCR Master Mix according to the manufacturer's protocol (Applied Biosystems Inc.). Samples with an RNase P C t value above 32 were excluded from further analysis. CopyCaller Software v2.0 (Applied Biosystems Inc.) was used to calculate CNs.
Real-time quantitative PCR analysis
The relative expression level of the selected genes was determined by quantitative real-time PCR in 12 primary melanoma cell lines (WM35, HT199, WM1789, WM793B, WM3211, WM1361, WM902B, WM39, WM278, WM983A, WM1366 and WM3248) using the LightCycler 480 Real-Time PCR System (Roche Diagnostics GmbH). Reverse transcription was carried out on total RNA (600 ng) using the High Capacity cDNA Archive Kit (Applied Biosystems). To perform qPCR reactions, SYBR premix Ex Taq (Takara Holding Inc., Kyoto, Japan) master mix was used. Primer sequences of 14 candidate genes are listed in Supplementary Table 1. PCR data were analysed using the Livak method (2 ÀDDC t ) with glyceraldehyde-3-phosphate dehydrogenase (Hs9999 9905_m1) as the reference gene and the median C t value of eight noninvasive cell lines as the control value (calibrator sample) [26] .
The cancer genome atlas data analysis aCGH data of melanoma samples deposited into the Skin Cutaneous Melanoma dataset (TCGA, Provisional) were analysed. The results shown are in whole on the basis of data generated by the TCGA Research Network (http:// cancergenome.nih.gov). The dataset includes GISTIC-CNA data of 366 melanoma samples. Data mining was performed using cBioPortal (http://www.cbioportal.org/) [27, 28] . All searches were carried out according to the cBioPortal's instructions.
Statistical analysis SPSS 19.0 (SPSS Inc., Chicago, Illinois, USA) was used for statistical analyses. The Shapiro-Wilk test was used to evaluate the normality of the data. Pearson's correlation coefficient was calculated to correlate the aCGH and qPCR data. The Mann-Whitney-Wilcoxon test was used to compare the mRNA expression of noninvasive cell lines with invasive ones. A P-value of less than 0.05 was considered statistically significant.
Results aCGH analysis
Detailed genomic analyses using the CytoChip ISCA array were carried out to evaluate the CN alterations in 18 human melanoma cell lines that originated from primary (n = 12) and metastatic (n = 6) tumours. A high degree of CN instability was identified across the genomes of all cell lines, involving CN gains in 1q, 6p, 7, 8q, 17q, 20 and 22q and CN losses in 6q, 9p and 10p. We observed CN alterations of several melanoma-related genes (Fig. 1) .
Recurrent regions related to invasiveness
To identify genomic alterations that are uniquely related to the invasive potential of melanomas, in-vitro invasion assays were performed on cell lines derived from primary malignant melanomas (WM35, HT199, WM1789, WM793B, WM3211, WM1361, WM902B, WM39, WM278, WM983A, WM1366 and WM3248) to determine the invasive potential of each cell line. According to the Matrigel invasion assays, we observed invasive cells in four out of the 12 cell lines that originated from primary melanoma tissues (Fig. 2) .
Several CN alterations occurred at significantly higher frequencies in cell lines showing invasive behaviour compared with the noninvasive lines ( Table 2) . Although a number of these altered regions mapped to known regions of germline CNV, we did not exclude these from further analyses as well-validated cancer relevant genes have been known to locate in regions of germline CNV [29, 30] .
We identified CN changes on 7q and 12q that appeared specifically in cell lines with invasive behaviour (Fig. 3a) . The targeted genes within these regions included the loss of several invasion-related genes (PTPN12, ADAM22, FZD1, TFPI2, GNG11, COL1A2, SMURF1, VGF, RELN and GLIPR1). In addition, the gains of 5p13 and 8q24 were present not just in invasive cell lines, but in metastasis-derived cell lines as well, harbouring GDNF (5p13.1), GPAA1, PLEC and SHARPIN (8q24.3) as invasion-related genes.
Copy number alterations of candidate genes in melanoma tumour samples
The Skin Cutaneous Melanoma dataset (TCGA, Provisional) provides the opportunity to determine the relevance of the alterations associated with invasive melanoma cell lines in native melanoma tissues. As most of the melanoma samples are metastatic and there are no available data on the invasive capacity of the primary tumours in the TCGA database, we focused on the genes (GDNF, GPAA1, PLEC, SHARPIN), in which CNAs were detected not uniquely in invasive but also in metastasis-derived cell lines, assuming the role of these genes in both invasion and metastasis formation.
These genes were not altered by CN changes in the primary lesion. Interestingly, GPAA1, PLEC and SHARPIN were coamplified in 26 metastatic samples, whereas GDNF was found to be amplified only in 14 metastatic tissues.
Relative mRNA expression of candidate genes
To determine the influence of CN alterations on the gene expression, we examined the relative mRNA level of the 14 candidate genes using the real-time PCR method. Seven of these genes (GLIPR1, PTPN12, ADAM22, FZD1, SMURF1, VGF and RELN) were either upregulated or downregulated in the same manner as was expected from gene CNs on the basis of aCGH data (Fig. 4a) . The relative mRNA expressions of FZD1 and SMURF1 genes were significantly lower in invasive cell lines compared with noninvasive ones. By correlating the relative expression levels (log2 transformed) with aCGH results (log2 ratios), we identified four genes (PTPN12, ADAM22, FZD1 and SMURF1) in which the mRNA level was correlated significantly with CN changes (Fig. 4b) .
Validation of aCGH data
The real-time quantitative PCR method was performed using TaqMan CN assays to detect CNs of COL1A2, RELN and GLIPR1 genes. Pearson's correlations were then calculated between the aCGH data using the mean log2 ratios of probes covering the aforementioned genes ( Fig. 3a) and the normalized CNs were determined using the qPCR method. Good concordance was found between the data derived from the aCGH and qPCR methods. The correlation coefficients showed moderate and strong correlations between our datasets: 0.659, 0.695 and 0.555, respectively (P = 0.003, 0.001, 0.017).
Discussion
Cytogenetic heterogeneity resulting from chromosomal instability is a major driving force of melanoma progression. Invasion is one of the first steps of metastasis formation in primary tumours; however, insufficient data are available on the genetic alterations involved in this initial process in melanoma. In this study, we used whole-genome aCGH profiling to detect chromosomal alterations in a set of melanoma cell lines.
According to our aCGH results, the overall pattern of genomic alterations was in close agreement with previously published data [30] [31] [32] [33] [34] . Gains of whole chromosomes or chromosome arms were observed across the 1q, 6p, 7, 8q, 17q, 20 and 22q regions, whereas losses were frequently found in chromosomes 6q, 9p and 10p. CN changes of several well-known oncogenes (EGFR, NEDD9, MYC and BRAF) and tumour-suppressor genes (CDKN2A, CDKN2B) related to melanoma progression were detected [35] [36] [37] [38] [39] .
Our main goal was to identify the invasive potential of multiple melanoma cell lines derived from primary melanomas and compare the CN changes between the Invasive potential of primary tumour-derived cell lines. Cells were cultured in Matrigel invasion chambers for 24 h. Following incubation, the invaded cells were fixed and stained with haematoxylin-eosin (a). The data are presented as the mean SD of three independent experiments (b). invasive and the noninvasive subgroups. We report several CN alterations that were uniquely detected in invasive cell lines. Loss of 7q appeared to be associated with invasive behaviour, targeting genes whose deletion or downregulation can potentially increase melanoma cell invasion (e.g. PTPN12, ADAM22, FZD1, TFPI2, GNG11, COL1A2, SMURF1, VGF and RELN). According to the mRNA expression analyses of this study, downregulation of PTPN12, ADAM22, FZD1, SMURF1, VGF and RELN genes was characteristic of the invasive cell lines compared with noninvasive ones. Although alterations in these genes have already been reported in a variety of invasive tumours, we provide the first evidence that the structural and functional alterations of these genes play a fundamental role in melanoma invasion [40] [41] [42] [43] [44] [45] [46] [47] .
According to previous studies, after the translocation of the GLIPR1 (GLI pathogenesis-related 1) protein to the cell surface, the soluble N-terminal domain of the molecule is exposed to the extracellular space, which can lead to invasion [48, 49] . In the present study, gain of the GLIPR1 gene was observed specifically in invasive cell lines. The mRNA expression level of the GLIPR1 gene was notably higher in invasive cell lines than in noninvasive lines, confirming that upregulation of the gene is associated with increased invasive potential in melanoma [48] .
We also aimed to identify CN alterations that appeared in the metastatic-derived cell lines besides the invasive primary lines. We found that the gain of GDNF (5p13.1), GPAA1, PLEC and SHARPIN (8q24.3) genes was detected in invasive and metastatic cell lines, indicating the possible role of these genes in both invasion and metastasis formation. In addition, these genes showed CNAs in metastatic melanoma tissues of the TCGA (provisional) melanoma dataset, supporting the relevance of these genes during the progression and metastasis formation of melanoma cells. Results of previous studies have shown that upregulated GDNF (glial cell-derived neurotrophic factor) can induce the proliferation and invasion of melanoma cells by activating the MAPK and PI3K pathways [50, 51] . The overexpression of GPAA1 (glycosylphosphatidylinositol anchor attachment 1) could also induce tumour invasion [52, 53] . Plectin (PLEC) is a multifunctional plakin protein that is essential for the integrity of skin, skeletal and cardiac muscle; it can regulate actin assembly and cell migration [54] . In addition, a recent study showed the role of overexpressed SHARPIN (SHANK-associated RH domain interactor) in the activation of the NFκB pathway and its downstream targets affecting cell invasion and metastasis [55] . The function of GPAA1, PLEC and SHARPIN in association with melanoma invasion and metastasis formation has not been mentioned previously.
Conclusion
Our systematic comparison of CN alterations between cell lines with different invasive properties showed several remarkable genomic alterations in invasive melanoma cells. CN changes in various invasion-related genes were observed for the first time in invasive melanoma cell lines. Furthermore, our data highlight the possible role for the gain of GDNF, GPAA1, PLEC and SHARPIN genes in metastasis formation as well. Our genomic analysis of human melanoma cell lines and the classification of CN alterations associated with melanoma invasiveness thus provide novel candidate genes for further functional studies. 
